ATE453663T1 - Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie - Google Patents

Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie

Info

Publication number
ATE453663T1
ATE453663T1 AT05734245T AT05734245T ATE453663T1 AT E453663 T1 ATE453663 T1 AT E453663T1 AT 05734245 T AT05734245 T AT 05734245T AT 05734245 T AT05734245 T AT 05734245T AT E453663 T1 ATE453663 T1 AT E453663T1
Authority
AT
Austria
Prior art keywords
compositions
group
polypeptides
immunotherapy
vaccines
Prior art date
Application number
AT05734245T
Other languages
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis filed Critical Mutabilis
Application granted granted Critical
Publication of ATE453663T1 publication Critical patent/ATE453663T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05734245T 2004-03-26 2005-03-29 Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie ATE453663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290818A EP1580195A1 (de) 2004-03-26 2004-03-26 Zusammensetzungen von Polypeptiden spezifisch für pathogene ExPEC E. coli, sowie deren Anwendung als Vakzine und in der Immuntherapie
PCT/EP2005/003972 WO2005097823A1 (en) 2004-03-26 2005-03-29 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy

Publications (1)

Publication Number Publication Date
ATE453663T1 true ATE453663T1 (de) 2010-01-15

Family

ID=34854730

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05734245T ATE453663T1 (de) 2004-03-26 2005-03-29 Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie

Country Status (7)

Country Link
US (2) US20090081224A1 (de)
EP (3) EP1580195A1 (de)
JP (1) JP2007530022A (de)
AT (1) ATE453663T1 (de)
CA (1) CA2559910A1 (de)
DE (1) DE602005018615D1 (de)
WO (1) WO2005097823A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1580195A1 (de) * 2004-03-26 2005-09-28 Mutabilis SA Zusammensetzungen von Polypeptiden spezifisch für pathogene ExPEC E. coli, sowie deren Anwendung als Vakzine und in der Immuntherapie
ITRM20050422A1 (it) * 2005-08-05 2007-02-06 Consiglio Nazionale Ricerche Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico.
CA2662507C (en) 2006-12-26 2015-04-28 Helen M. Blau Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
EP2599496A1 (de) 2011-11-30 2013-06-05 Kenta Biotech AG Neuartige Targets von Acinetobacter baumannii
US20160296595A1 (en) * 2013-11-15 2016-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) A rho gtpase activator for use as antimicrobial agent
CL2014001126A1 (es) * 2014-04-29 2014-08-29 Univ Chile Composición farmacéutica útil como vacuna contra bacterias escherichia coli productoras de shigatoxinas (stec), que comprende al menos un antígeno o una proteína de membrana externa inmunogénica o proteína inmunogénica asociada y conservada en cepas stec.
WO2017005670A1 (en) * 2015-07-04 2017-01-12 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CA3110111A1 (en) 2018-08-09 2020-02-13 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
US20250011375A1 (en) * 2021-10-29 2025-01-09 Vaxxinova Us, Inc. Methods and compositions for preventing infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7608000A (en) * 1999-09-22 2001-04-24 Research Foundation Of The State University Of New York, The Identification of a vaccine candidate from an extraintestinal isolate of e. coli
EP1342784A1 (de) * 2002-03-06 2003-09-10 Mutabilis S.A. ExPEC-spezifische Proteine, entsprechende Gene und ihre Verwendungen
EP1580195A1 (de) * 2004-03-26 2005-09-28 Mutabilis SA Zusammensetzungen von Polypeptiden spezifisch für pathogene ExPEC E. coli, sowie deren Anwendung als Vakzine und in der Immuntherapie

Also Published As

Publication number Publication date
US20090081224A1 (en) 2009-03-26
EP2135876A3 (de) 2010-06-16
DE602005018615D1 (de) 2010-02-11
EP1727828A1 (de) 2006-12-06
JP2007530022A (ja) 2007-11-01
EP2135876A2 (de) 2009-12-23
EP1580195A1 (de) 2005-09-28
WO2005097823A1 (en) 2005-10-20
CA2559910A1 (en) 2005-10-20
US20100316647A1 (en) 2010-12-16
EP1727828B1 (de) 2009-12-30

Similar Documents

Publication Publication Date Title
RU2431671C2 (ru) Химерные, гибридные и тандемные полипептиды менингококкового белка nmb1870
EA200870237A1 (ru) Последовательности пептидов и композиции
NO20063026L (no) Antistoffer
AR064642A1 (es) Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
UA103774C2 (uk) Модифіковані поліпептиди бичачого гранулоцитарного колонієстимулювального фактора (g-csf) та їх застосування
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
ATE453663T1 (de) Zusammensetzungen von für pathogene stämme spezifischen polypeptiden und deren verwendung als impfstoffe und in der immuntherapie
CY1119916T1 (el) Ανοσογονικη συνθεση
NZ609216A (en) Anticancer fusion protein
RU2011154363A (ru) Комбинации клад rrgb пневмококков
PH12015500461A1 (en) Novel il-17a binding molecules and medical uses thereof
EA202190240A1 (ru) Варианты рекомбинантного белка
MX2009007261A (es) Vacuna de peptido foxp3.
AR075933A1 (es) Composiciones polipeptidas y de inmunizacion conteniendo polipeptidos positivos gram y metodos de uso
BRPI0715331B8 (pt) polipeptídeo que compreende uma porção n-terminal e uma porção c-terminal, e uso do mesmo
WO2010026219A3 (en) New tomato ethylene response factors and uses thereof
MX2023001219A (es) Constructos de vacuna y sus usos contra infecciones causadas por staphylococcus.
ATE551353T1 (de) Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten
TW200716166A (en) Lawsonia intracellularis immunological proteins
WO2021113440A3 (en) Oligopeptide, testing kit thereof, medical composition thereof and use of medical composition
SG170092A1 (en) Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
NO20085201L (no) Rekombinante novirhabdoviruser og deres anvendelse
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
ATE443079T1 (de) Immunogene glycopeptide. screening- und herstellungsverfahren sowie verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties